Introduction p21-Activated kinase (Pak), a serine/threonine kinase, was identified as downstream signaling effector for the Rho GTPases Cdc42 and Rac1 (Manser et al., 1994) . Paks contain an N-terminal p21 GTPase-binding domain (PBD) and a C-terminal kinase domain (Bokoch, 2003; Hofmann et al., 2004) . Paks 1-3 are distinguished from Paks 4-6 by an N-terminal regulatory domain that contains a Pak auto-inhibitory domain (PID) that overlaps partially with the PBD. The PID domain has been widely used as specific Pak1-3 inhibitor, as this fragment binds to one Pak molecule of the inactive Pak homodimer and inhibits the kinase of the other Pak molecule in trans (Lei et al., 2000) . Paks regulate many cellular processes, including cytoskeletal dynamics, motility, survival, transcription and angiogenesis. However, deregulated Pak is also involved in cell transformation, tumorigenesis and metastasis (Bokoch, 2003; Hofmann et al., 2004; Kumar et al., 2006) . Amplification of the PAK1 locus or Pak kinase hyperactivity was observed in certain bladder, breast, colon and ovarian cancers (Mira et al., 2000; Kumar and Vadlamudi, 2002; Balasenthil et al., 2004; Holm et al., 2006) . Pak homologs in lower organisms and mammalian group A Paks have been implicated in several key steps of cell-cycle regulation, including Pak1-dependent hyperproliferation of breast cancer cells (Mira et al., 2000) , Cdc2-mediated threonine phosphorylation of Pak in mitosis (Banerjee et al., 2002; Thiel et al., 2002) , increased histone H3 phosphorylation by active Pak1 (Li et al., 2002) and upregulation of cyclin D1 and D2 (Balasenthil et al., 2004; Nheu et al., 2004) .
G 2 /M transition and mitosis depend on a complex regulatory network clustered around the Cdk1-cyclin B1 complex. Cdk1 phosphorylates mammalian Pak1 at a threonine residue without leading to changes in Pak1 activity (Banerjee et al., 2002; Thiel et al., 2002) . The entire mitotic circuit including Cdk1-cyclin B1 activation, centrosome maturation, spindle assembly, anaphase onset and cytokinesis is regulated by polo-like kinase 1 (Plk1) and Aurora kinases. A considerable body of work indicates that normal cell division is exceedingly dependent on tightly controlled Plk1 expression levels and kinase activity (Barr et al., 2004; Lowery et al., 2005; van Vugt and Medema, 2005; Xie et al., 2005) . This is prominently highlighted by the timed synthesis and degradation of Plk1 in concert with phosphorylation and activation of the kinase, and by targeting of Plk1 to specific subcellular structures (Lenart et al., 2007) . Plk1 has been reported to be essential in the assembly of functional bipolar spindles, with proper stability and tension, necessary for chromosome condensation and segregation (Seong et al., 2002; Sumara et al., 2004; van Vugt et al., 2004; Glover, 2005) .
We decided to determine whether Pak contributes to mitotic progression and which steps will be affected, and to identify potential downstream proteins required for entry and/or completion of mitosis. Because at least three Pak isoforms are expressed in HeLa cells and signaling specificity between Pak isoforms in regard to cell-cycle control is not apparent, we used a gain or lossof-function approach to alter Pak activity in these cells. We show here that Pak activity is required for entry into mitosis and proper spindle formation and this is at least partially due to the regulatory effect of Pak on Plk1. Increased Pak expression, as commonly seen in breast and ovarian cancer cells, caused elevated Plk1 phosphorylation and activity as well as substantial upregulation of cell proliferation, thus identifying Pak as an important target for tumor drug design.
Results
Pak activity is required for mitotic progression Previous studies in breast cancer cell lines revealed overexpression and deregulation of Pak in these highly proliferating cells (Mira et al., 2000) . Transient introduction of PID into one of these cell lines, MDA-MB 435, caused a decline of cell proliferation, whereas transient transfection of wild-type or kinase active Pak into other cell types led to a substantial increase in proliferation. In order to determine the effect of Pak1 activity on cell proliferation in more detail, tetracyclineinducible HeLa cell lines were generated that express Myc-Pak1 wild-type (wt), green fluorescent protein (GFP)-PID wt and an inactive mutant GFP-PID (L107F) under the control of a doxycycline-repressible promoter. Multiple clones for each of the constructs were selected which showed no expression in noninduced conditions ( þ dox) and 3 to 4-fold overexpression for Myc-Pak1 wt above endogenous protein levels (Àdox) (Supplementary Figure S1) . PID expression abolished serum-induced activation of endogenous Pak, which was not observed when cells were grown in doxycycline or when the PID mutant was expressed (DerMardirossian et al., 2004) . Using in-vitro kinase assays an activation profile for Pak1 during mitosis was established, which revealed that Pak1 activity increased during the G 2 /M transition (7-7.5 h after release from thymidine block) with an activity peak as cells progressed through earlier steps of mitosis, and subsequent decrease of Pak activity toward the end of mitosis (Figure 1a ). Autophosphorylation of Pak followed the profile of phosphorylated Pak substrate histone H4. Mitotic Rac/Cdc42 activity in nocodazole-arrested HeLa cell lysates was negligible (data not shown). This suggests that GTPase-independent Pak activity contributes to events during the G 2 /M transition and/or early mitosis.
To examine the role of Pak1 in cell proliferation, growth curves of representative cell lines expressing (Àdox) or not expressing ( þ dox) Pak1 wt, PID wt and PIDmut were obtained (Figure 1b ). Pak1 wt expression caused a substantial increase in proliferation when compared with cells without altered Pak expression levels. No obvious differences in cell growth were detected between Pak1 wt or active Pak1 (L107F T423E) expressing cells (data not shown). In contrast, PID wt expression resulted in severely impaired cell growth when compared to the same cell line without PID wt expression or with cells expressing the inactive mutant PID. Cell-cycle analysis indicated faster progression of Pak1 wt-expressing cells and a substantial decline in cell-cycle progression in PID wt-expressing cells (Figure 1c ). An increase in Pak expression induced a threefold increase in the mitotic index, whereas inhibition of Pak activity had no effect (Figure 1d ). On the other hand, when cells were synchronized by single thymidine block and released into nocodazole, which prevents spindle assembly checkpoint inactivation, loss of Pak activity was detrimental. Phosphohistone H3 analysis showed that PID-expressing cells could not be properly blocked in mitosis and the mitotic index dropped by 50%, suggesting that inhibition of Pak activity caused defects related with proper spindle assembly or with nocodazole-mediated mitotic arrest ( Figure 1e) . Expression of the loss-of-function mutant PID did not alter any cell-cycle parameters in HeLa cells. As the PID domain of Pak1 inhibits all three group A Pak isoforms (Pak1-3), this data indicate that loss of Pak activity is incompatible with normal cell proliferation.
Because gain or loss of Pak activity may affect the expression or timing of cell-cycle parameters, we evaluated representative markers in Pak1 wt or PID wt-expressing cells (Supplementary Figure S2) . No substantial changes were detected for cyclin D1, cyclin E or cyclin B1. Phosphorylation of histone H3 is considered a marker for proper progression of mitosis and is linked to chromosome condensation and segregation (Nowak and Corces, 2004; Bode and Dong, 2005) . Histone H3 can serve as a Pak substrate in vitro and is phosphorylated in breast cancer cells expressing constitutively active Pak (Li et al., 2002) . Pak activity may also contribute indirectly via its effect on Aurora kinases to increased phospho-H3 content. Although loss of Pak activity in PID-expressing cells did not alter histone H3 phosphorylation substantially, we detected an increase of phospho-histone H3 in Pak1 wt-expressing cells (Supplementary Figure S2) . This data match well with the substantial increase in the mitotic index for Pak1 wtexpressing cells and suggest that, as observed in certain cancer cells, high Pak activity can trigger proliferation by enhancing mitosis. If Pak exerts such a pronounced effect on Plk1, colocalization of these proteins during early mitotic phases should be apparent. Confocal analysis detected endogenous Pak1 and Pak2 at the spindle poles, the central spindle and the midbody. Exogenously expressed Myc tagged Pak showed the same localization pattern as endogenous Pak1 and Pak2. Plk1 localization was strikingly similar to the pattern observed with endogenous or Myc-tagged Pak1. Co-staining of mitotic HeLa cells with Pak and Plk1 antibodies revealed co-localization on the spindle poles, the central spindle and the midbody (Figure 2b ). Co-localization of Plk1 with Pak was also evident when various Pak mutants were tested (Supplementary Figure S4 ). An interaction of Pak with Plk1 was demonstrated using a pan-Pak antibody to coimmunoprecipitate Pak and Plk1 from mitotic cells (Figure 2c ). This association seems to be rather weak and transient as the converse immunoprecipitation was not successful.
Next, we wished to determine whether Plk1 activity was regulated by Pak-induced phosphorylation of Plk1. To demonstrate that Plk1 is a direct target for Pakmediated phosphorylation, kinase active glutathione S-transferase (GST)-Pak1, wild-type Plk1 and constitutively active Plk1 T210D were expressed in Escherichia coli and affinity purified to homogeneity (Supplementary Figure S5a ). Co-incubation of Pak with Plk1 during the kinase assay enhanced Plk1 phosphorylation and activity as evidenced by an increase in casein phosphorylation ( Figure 3a ). Phosphoamino acid analysis of Figure 1 P21-Activated kinase (Pak) regulates cell-cycle progression. (a) Anti-Myc immunoprecipitates of lysates derived after release of synchronized HeLa cell lines expressing (Àdox) or not expressing ( þ dox) Myc-Pak1 wt were subjected to in-vitro kinase assay using histone H4 as substrate. Pak1 expression was confirmed by anti-Myc immunoblot. Cyclin B1 expression was verified (data not shown). Two independent experiments were performed. (b) HeLa cell lines expressing (Àdox) or not expressing ( þ dox) Pak1 wt, Pak auto-inhibitory domain (PID) wt and PIDmut (PID L107F) were synchronized and plated at a density of 2.5 Â 10 4 cells per well. Cells were grown for up to 6 days in 0.5% serum in the presence or absence of doxycycline and counted every 24 h. Cell counts were performed in triplicate for three independent experiments. Protein expression at days 5 and 6 is shown by anti-Myc immunoblot for Pak1 wt or anti-green fluorescent protein (GFP) immunoblot for PID wt and PIDmut. Values are expressed as percent of ( þ dox) control ( ± s.e.m.) from triplicates of one representative experiment (n ¼ 3); *Po0.05, **Po0.01. (c) Loss of Pak activity affects entry into G 2 /M. HeLa cell lines expressing (Àdox) or not expressing ( þ dox) Pak1 wt, PID wild-type (wt) and PID mutant were released after a double thymidine block, stained with propidium iodide (PI) at the indicated time points after the release, and analysed for DNA content. The numbers indicate the percentage of cells at G 1 /S or G 2 /M stages and are representative of 2-3 independent experiments. (d) Increased Pak1 expression accelerates mitotic entry. Pak wt and PID wt cells ( þ /Àdox) were analysed by flow cytometry at the indicated time points after thymidine block and release using phospho-histone H3 staining combined with PI. One representative experiment is shown (n ¼ 2-3). (e) Pak activity is required for mitotic entry. HeLa cell lines expressing (Àdox) or not expressing ( þ dox) Pak1 wt, PID wt and PIDmut were synchronized with a double thymidine block and released in the presence of nocodazole. Cells were analysed using phospho-histone H3 staining combined with PI. One representative experiment is shown (n ¼ 3), for PID mutant (n ¼ 2).
in-vitro phosphorylated Plk1 indicated increased serine phosphorylation after incubation with active Pak (data not shown). To confirm that Pak1 activity is required for Plk1 phosphorylation and activation, hemagglutinin (HA)-Plk1 wt was transfected into HeLa cells with or without Pak1 expression (À/ þ dox). After nocodazole treatment Pak and Plk1 immunoprecipitates were used for in-vitro kinase assays (Figure 3b ). Pak immunoprecipitations confirmed Pak activation by nocodazole arrest. Transfected Plk1 wt exhibited already some kinase activity without Pak overexpression, as expected for mitotic Plk1, but the increase in Pak activity (Àdox) enhanced Plk1 phosphorylation by 41% and Plk1-mediated casein phosphorylation by 65% (Figure 3b ). To assess in-vivo phosphorylation of Plk1 by Pak, radioactive labeling of nocodazole-treated HeLa cells, which expressed either endogenous Pak ( þ dox) or additionally Myc-Pak1 (Àdox) was performed. MycPak1 expression caused a substantial increase of Plk1 phosphorylation, which was dependent on mitotic arrest (Figure 3c ).
Plk1 Ser49 is a Pak phosphorylation site
Our in-vitro data indicated an increase in Plk1 serine phosphorylation when active Pak was present. To confirm this in vivo, we transiently expressed HA-Plk1 wt or a vector control in HeLa cells expressing Myc-Pak1. Cells were metabolically labeled with orthophosphate and arrested with nocodazole. Immunoprecipitation of Plk1 and analysis of the excised band in phosphoamino acid analysis revealed again a substantial increase in phospho-serine, whereas the phospho-threonine content did not change (Figure 4a ). The serine residues at positions 49 and 137 of mammalian Plk1, located in the kinase domain and surrounded by positively charged residues, are potential targets for phosphorylation by Pak. After mutation to alanine, we performed an in-vitro kinase assay with Plk1, Plk1 S49A and Plk1 S137A immunoprecipitated from transiently transfected HeLa cells in the presence of active GSTPak. The mutation of Ser49 in Plk1 decreased Plk1 and Plk1 substrate (casein) phosphorylation, whereas Plk1 wt and Plk1 Ser137 mutant phosphorylation were comparable (Figure 4b) . A similar phosphorylation profile was observed for transiently expressed Plk1, Plk1 S49A and Plk1 S137 in HeLa cells stably expressing the constitutively active form of Pak (data not shown). Plk1 S49A mutant was also expressed in E. coli and Figure S5b) . Using recombinant proteins Pak-induced Plk1 S49A phosphorylation was again visibly reduced compared to Plk1 wt (Figure 4c) . Additionally, HeLa cells transiently expressing Plk1, Plk1 S49A, Plk1 S137A or vector control were metabolically labeled with orthophosphate in the presence of nocodazole. When these cells were arrested in mitosis, conditions that favor Pak activation, we observed increased Plk1 and Plk1 S137A phosphorylation, whereas incorporation of phosphate into Plk1 S49A was markedly decreased, although protein expression was equal (Figure 4d ). The reduced phosphorylation of Plk1 Ser49 mutant correlated with decreased casein phosphorylation. Phosphoamino acid analysis of in-vivo labeled Plk1 proteins revealed reduced serine phosphorylation for Plk1 S49A (Figure 4e ). Thus, Pak can phosphorylate Ser49 of mammalian Plk1, which enhances Plk1 activity.
Loss of Pak activity leads to spindle defects
Because Pak activity seems to be critical for proper timing of mitotic entry and nocodazole-dependent arrest in mitosis, we determined if loss of Pak activity will lead to noticeable mitotic defects. Inhibition of endogenous Pak activity caused a higher incidence of nonfunctional spindle structures, in particular monopolar and multipolar spindles, or chromosome alignment defects, which might indicate loss of spindle tension (Figure 4f) . No obvious defects were observed in anaphase, telophase or cytokinesis (data not shown). In contrast, raising Pak levels 3 to 4-fold by inducing Myc-Pak1 wt expression (Àdox) had no effect on spindle formation. Next, we determined how loss of Plk1 phosphorylation on Ser49 affects Plk1 function in mitosis. After transfection of HA-Plk1 wt or Plk1 S49A HeLa cells were stained for HA, tubulin and DNA, and scored for mitotic phenotypes by microscopy. In properly progressing cells, Plk1 wt localized to the spindle poles of the bipolar spindles, redistributed to the metaphase plate and concentrated in the midbody during telophase. Although overexpression of Plk1 wt disturbed to some extent mitotic spindle assembly, expression of Plk1 S49A increased considerably the frequency of monopolar or multipolar spindles and led to partial loss of Plk1 S49A at the spindle poles (Figure 4f ). The localization of Plk1 S49A in HeLa cells without spindle defects resembled Plk1 wt distribution. Defects in later phases of mitosis or cytokinesis were not apparent.
Discussion
Collectively, our data provide evidence that Pak1 fulfills a critical role during mitotic progression. Pak recruitment and activation at the centrosomes seems to be independent of Rac/Cdc42 activity, but is instead regulated by a GIT1/PIX complex (Zhao et al., 2005) . Pak activity peaks at mitotic entry and is sustained during mitotic progression. Our data show that an increase in Pak expression, as frequently observed in several cancers, provides transformed epithelial cells with a substantial growth advantage. Enhanced cell proliferation was not dependent on expression of constitutively active Pak, as wild-type and active mutant Pak increased HeLa cell proliferation to a similar extent (data not shown). In contrast to Thullberg et al. (2007) , who analysed the involvement of Pak in cell-cycle progression in NIH3T3 cells and in murine fibroblast cell lines, we did not detect changes in cyclin D1 expression by inhibition of Pak via PID or unspecific cell-cycle effects by the PID mutant. The PID mutant has been widely used as inactive PID control (Bokoch, 2003) . Differences in cell types, synchronization protocol and expression levels may account for this divergence. A considerable body of work indicates that normal cell division is dependent on tightly controlled Plk1 expression levels and kinase activity (Barr et al., 2004; Lowery et al., 2005; van Vugt and Medema, 2005; Xie et al., 2005) . This study shows that Pak1 regulates Plk1 activity during G 2 /M transition or early mitosis. Cell cycle-dependent Pak activity preceded Plk1 activity and was essential for mitotic progression. Little is known about upstream regulation of Plk1 kinase activity. Phosphorylation of Thr210 and Ser137 in the Plk1 kinase domain are important for Plk1 activity and function, but other phosphorylation sites exist (Jang et al., 2002; Barr et al., 2004; van de Weerdt and Medema, 2006) . Kinases such as SLK, Stk10 and PKA have been implicated in phosphorylation of the catalytic domain of mammalian Plk1 (Ellinger-Ziegelbauer et al., 2000; Barr et al., 2004; van de Weerdt and Medema, 2006) . It was reported that the activity of SLK, a homolog of Xenopus Plkk1, increased during the G 2 /M transition (Ellinger-Ziegelbauer et al., 2000) . SLK and Pak belong both to the Ste20-like kinase family and share a highly homologous catalytic domain, although their mode of activation differs. Pak localizes like Plk1 to the centrosomes and spindle poles, whereas details about SLK localization and activation during mitosis are unknown. Among other functions, Plk1 controls the localization of another Pak target, Aurora A, to the centrosomes (De Luca et al., 2006) .
It appears that phosphorylation of Plk1 Ser49 is important in establishing a functional bipolar spindle and proper spindle tension, as spindle defects and alignment abnormalities occurred with loss of Pak function and with the Plk1 mutant. The phosphorylation of Plk1 on Ser49 might be a transient event, required only during a very limited point in time during mitosis. This situation would be reminiscent of results by van de Weerdt et al. (2005) who demonstrated transient phosphorylation of Ser137 in mitosis. As Plk1 S49A protein was expressed at similar levels as Plk1 wt in HeLa cells and E. coli, migrated at the same molecular weight as Plk1 wt and localized to the spindle poles in the majority of HeLa cells, we have no indication of a structural disruption in this Plk1 mutant. Although this site, Ser49, is conserved in all mammalian organisms, it is substituted for threonine in some other species. As the surrounding amino-acid residues are conserved, this threonine residue could also represent a Pak phosphorylation site. Although Pak may have additional targets that enable proper mitotic progression, as for example microtubule dynamics-related proteins, including stathmin (Bokoch, 2003) , tubulin cofactor B (Vadlamudi et al., 2005) , Aurora A (Zhao et al., 2005) or yet unidentified proteins, it is interesting to note that both, Pak and Plk1, are often overexpressed in tumors and that their combined action may contribute to tumorigenesis.
Materials and methods
Cell culture and synchronization HeLa cells (ATCC) were grown in Dulbecco's modified Eagle's medium (DMEM), 10% fetal bovine serum (FBS), 2 mM L-glutamine and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Invitrogen, Carlsbad, CA, USA). This medium was supplemented with 1 mg/ml of doxycycline (BD Biosciences, Bedford, MA, USA) for HeLa Tet-off cell lines. To induce expression, doxycycline was removed from the media and 10% of tetracycline-free FBS (BD Biosciences) was used. Cells were synchronized at the G 1 /S-phase boundary by double thymidine block and release. Cells were treated with 2.5 mM thymidine (Sigma, MO, USA) for 16 h, released in fresh media for 8 h and again incubated with 2.5 mM thymidine for 16 h. After the second release experiments were performed at specified time points. Where indicated 100-250 ng/ml of nocodazole (Sigma) was added to arrest cells in mitosis.
Plasmids and transfections
Myc-Pak1 wt, pGEX-Pak1 wt, pCMV6-PID wt and PID L107F (PIDmut) plasmids have been described (Shalom-Barak and Knaus, 2002) . Myc-tagged Pak1 wt was excised from pCMV6M with Nhe1 and Not1 and inserted into the same restriction sites of pTRE2hyg (BD Biosciences-Clontech, Mountain View, CA, USA), as described before for enhanced green fluorescent protein (EGFP)-PID wt and EGFP-PID L107F (DerMardirossian et al., 2004) . The Plk1 expression plasmids, pCDLSRa-HA-Plk1 and pET23d-His-Plk1 were kindly provided by E Nishida (Kyoto University, Japan). Plk1 substitution mutation was generated by PCR-based mutagenesis using the QuikChange (Agilent-Stratagene, Santa Clara, CA, USA) site-directed mutagenesis kit and was verified by sequencing. Expression and purification of E. coli-expressed Plk1 was according to QIAexpressionist (Qiagen, Germany). Transient transfections of HeLa cells were performed using FuGene (Roche, Indianapolis, IN, USA) or Lipofectamine Plus (Invitrogen) according to the manufacturers' instructions. In total 3 Â 10 5 cells were transfected with 0.1-1 mg of plasmid DNA. The cell monolayer was washed twice with phosphatebuffered saline (PBS) and lysed in the cold lysis buffer 24-48 h post-transfection. The cell lysates were clarified by centrifugation at 15 000 r.p.m. for 10 min at 4 1C.
Antibodies and western blot analysis Lysis buffer, gel electrophoresis, immunoblotting and detection were essentially as reported earlier (Shalom-Barak and Knaus, 2002) . Primary antibodies: Plk1 (Abcam, Cambridge, MA, USA; Invitrogen-Zymed, Carlsbad, CA, USA), phosphohistone (Millipore, Danvers, MA, USA), Pak polyclonal antibody and pre-immune serum (Knaus et al., 1995) , Pak1 (Epitomics, Burlingame, CA, USA), Pak2 (Cell Signaling, Danvers, MA, USA), histone H3 (Abcam), cyclin B1, cyclin E, HA and Myc (Santa Cruz Biotech, Santa Cruz, CA, USA, Millipore), actin (Sigma), GFP (Invitrogen), a-tubulin (clone DM1A; Sigma), cyclin D1 and GM130 (BD Biosciences). Secondary antibodies anti-mouse or anti-rabbit immunoglobulin conjugated to horseradish peroxidase.
Immunoprecipitation and kinase assays
Cell lysates were incubated with anti-HA, anti-Myc, anti-Plk1, anti-Pak or preimmune serum for 2 h at 4 1C with constant rocking. Coated protein A or protein G beads were added for another hour. Immunoprecipitates were washed four times with lysis buffer and two times with kinase assay buffer (Pak kinase buffer was 100 mM HEPES, 20 mM MgCl 2 , 4mM MnCl 2 and 0.4 mM dithiothreitol (DTT); Plk kinase buffer was 25 mM HEPES, 10 mM MgCl 2 , 50 mM NaCl, 0.5 mM DTT, 20 mM b-glycerophosphate and 1 mM Na 3 VO 4 ). Pak1 and Plk1 kinase reactions were performed for 20 min at 30 1C in the presence of 10-20 mCi of [g-32 P]ATP (MP Biomedical, Solon, OH, USA) and 10-20 mM cold ATP. Histone H4 (5 mg) for Pak1 and casein (2 mg) for Plk1 per reaction were added as exogenous substrates. The reactions were terminated on ice by adding SDS sample buffer.
Flow cytometry analysis
For propidium iodide (PI) staining, cells were harvested at various time points and fixed with 70% ethanol at À20 1C overnight. Approximately 10 6 cells were incubated with 25 mg/ml of PI (Sigma) and 0.1 mg/ml of DNase free RNase A (Roche) and DNA content was determined with a FACSCalibur (Beckton Dickinson, CA, USA). Data were plotted by using CellQuest software; 10.000 events were analysed for each sample. Analysis of phosphorylated histone H3 was performed as described (Xu et al., 2002) . Briefly, cells were harvested at various time points and fixed in 70% ethanol at À20 1C overnight. After fixation cells were resuspended in PBS/0.25% Triton X-100 and incubated 15 min on ice. The staining with phospho-histone H3 antibody was performed for 3 h at room temperature in PBS/1% bovine serum albumin (BSA). After washing with PBS/1% BSA cells were incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit antibody or Cy5-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch Labs, ME, USA) for 30 min at room temperature. Cells were stained with PI and cellular fluorescence was recorded using a FACScan (Beckton Dickinson).
Microscopy
HeLa cells were grown on fibronectin-coated glass coverslips and transfected, where necessary, as described above. Altogether 24-48 h after transfection, cells were extracted with 80 mM Pipes pH 6.8, 1 mM MgCl 2 , 5mM ethylene glycol tetraacetic acid, 0.5% Triton X-100 and 10 mM taxol for 1 min at 37 1C. Fixation was in ice-cold methanol for 10 min, followed by permeabilization with 0.5% Triton X-100 for 10 min at room temperature. Blocking was in PBS with 2% BSA. Cells were stained with anti-HA, anti-Plk1, anti-Myc, anti-a-tubulin and 4-6-diamidino-2-phenylindole (DAPI) (Sigma). The secondary antibodies were goat anti-rabbit Alexa Fluor 488 and goat anti-mouse Alexa Fluor 568 (Invitrogen, Carlsbad, CA, USA). Images were taken on an Olympus IX70 microscope with MetaMorph version 6.1 software (Universal Imaging Corporation, PA, USA) or on a Bio-Rad Rainbow Radiance 2100 microscope (Laser 405, 488, 543 nm) with a Â 63 oil objective lens (Plan Apo, 1.4 na) and images were processed using Zeiss LSM ExaminerBio-Rad LaserSharp 2000 (version 6.0), Image J (version 1.34), and Photoshop CS. three-dimensional reconstruction from Z-series was made with IMARIS/AUTOQUANT software. Quantification of spindle defects was performed by counting 200 cells for each condition in three different areas on two coverslips each. For transiently transfected cells only HA-positive cells were counted. Each quantification was repeated 2-3 times.
Metabolic labeling
In total 1 Â 10 6 HeLa cells were incubated with 1 mCi of [ 32 P] H 3 PO 4 in phosphate-free DMEM supplemented with 2 mM L-glutamine and 10% dialysed FBS. After 4 h of labeling, the cells were washed twice with PBS and lysed. In some experiments cells were arrested in mitosis for 12 h using nocodazole and mitotic cells were collected by shake off. Labeling was then performed on mitotic cells in the presence of additional nocodazole. Endogenous Plk1 or transfected Plk1 was immunoprecipitated from the supernatants with anti-Plk1 or anti-HA monoclonal antibodies. The immunoprecipitates were washed four times with lysis buffer, resuspended in SDS sample buffer and resolved on 6-12% SDS-polyacrylamide gel electrophoresis. Proteins were transferred to polyvinylidene fluoride membrane (Bio-Rad, Hercules, CA, USA) or nitrocellulose (Bio-Rad) and exposed to X-ray film. Phosphoamino acid analysis was performed as described (Shalom-Barak and Knaus, 2002) .
Statistical analysis
When applicable data are shown as mean ± s.e.m. and differences were assessed by using a two-tailed Student's t-test, P-values of o0.05 were regarded as statistically significant. Significance levels were *Po0.05; **Po0.01 and ***Po0.001.
